Whitehawk Therapeutics Inc
WHWK | NASDAQ
$4.04
$0 (0.00%)
At close: Sep 22, 2026, 4:00 PM ET
$4.04
$0 (0.00%)
After-hours:
Sep 22, 2026, 7:30 PM ET
Company Profile
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Key Executives
| Name | Position |
|---|---|
| David J. Lennon | President, Chief Executive Officer & Director |
| Scott Giacobello | Chief Financial Officer, Treasurer, Investor Relations & Corporate Communications |
| Bryan Ball | Chief Technical Operations Officer |
| David Dornan | Chief Scientific Officer |
| Margaret Han Dugan | Chief Medical Officer |
| Neil Desai | Founder & Director |
| Stephen Rodin | Senior Vice President of Legal & General Counsel |
Whitehawk Therapeutics Inc
| Country | United States |
| IPO Date | Jul 31, 2017 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 32 |
| CEO | David J. Lennon |
Contact Details
2 Headquarters Plaza Morristown,
New Jersey 07960 United States
Stock Details
| Ticker Symbol | WHWK |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001422142 |
| CUSIP Number | 00032Q104 |
| ISIN Number | US00032Q1040 |
| SIC Code | n/a |
Add to Watchlist
Select watchlists to add or remove WHWK